MET and autosomal dominant polycystic kidney disease: Defective ubiquitination of c-Met caused hyperactivation of mTOR in PKD and treatment with a c-Met inhibitor resulted in the inhibition of mTOR activity and blocked cystogenesis in Pkd1-null mice model of ADPKD (Qin et al., 2010).